Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

22-01-2025(Wed) 21-01-2025(Tue) 20-01-2025(Mon) 17-01-2025(Fri) 16-01-2025(Thu)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
17 Mar, 2025 (Monday)



TIANJIN DEV(882)
Analysis¡G
Tianjin Development Holdings Limited (00882), as a diversified conglomerate, operates across multiple sectors including public utilities, pharmaceutical, hotel operations, and mechanical and electrical engineering. For the first half of 2024, the company recorded revenue of HK$1.82 billion, representing a slight decrease of 0.6% YoY, while profit attributable to shareholders declined by 22.5% to HK$288 million. Despite this, the interim dividend increased by 50.1% to HK5.18 cents per share, demonstrating robust cash flow generation. In terms of business segments, the pharmaceutical division achieved revenue of HK$895 million, up 7.4% YoY, primarily driven by the contribution from newly acquired Qingchun Kangyuan. The public utilities segment recorded revenue of HK$769 million, down 10.2% YoY, though with improved operating margins. Hotel operations revenue grew by 10.3% to HK$67 million, with average occupancy rate rising to 87.5%, reflecting strong post-pandemic recovery. Notably, the company completed the acquisition of a 65% stake in Qingchun Kangyuan during the period, further strengthening its pharmaceutical business portfolio. Meanwhile, it continued to optimize its asset structure through the divestment of stakes in Tianjin Pharmaceutical Group Finance and Tianjin Tanabe Seiyaku. As of end-June 2024, the company maintained a strong financial position with cash holdings of HK$6.17 billion against bank borrowings of HK$1.97 billion, with a healthy gearing ratio of 15.8%. Looking ahead, amid challenging external conditions, the company will maintain its prudent yet progressive strategy, focusing on consolidating operations while pursuing internal restructuring and integration to lay a solid foundation for long-term development. With its ample cash reserves and diversified business portfolio, the company demonstrates strong risk resilience and growth potential.
Strategy¡G
Buy-in Price: $2.09, Target Price: $2.30, Cut Loss Price: $1.98



Sunny Optical (2382.HK) - A full-year positive profit alert announced, and the premiumization of mobile products is expected to continue

Company profile

Sunny Optical Technology, founded in 1984, is a leading global manufacturer of optical components and products. Specializing in optical and optoelectronic product design, R&D, production, and sales, its key offerings include optical components (mobile phone lenses, automotive lenses, surveillance lenses, etc.), optoelectronic products (mobile phone camera modules, 3D optoelectronic modules, automotive modules), and optical instruments (microscopes, smart inspection equipment).

Positive profit alert for 2024

The company has issued a positive profit alert for 2024, expecting full-year net profit to reach RMB 2.64¡V2.75 billion, marking a YoY growth of 140.0%¡V150.0%, slightly exceeding market expectations. This growth is primarily driven by the recovery of the global smartphone market, with shipments rising to 1.22 billion units, strong demand for high-end models, and AI integration in smartphone hardware, resulting in a 13.1% YoY increase in mobile phone lens shipments and improved product mix, boosting ASP and gross margins. Additionally, the development of intelligent driving assistance systems increased the adoption rate of automotive lenses, with the company's total automotive lens shipments reaching 102 million units, a 12.7% YoY increase, meeting the previous guidance.

In 1H 2024, the company achieved revenue of RMB 18.86 billion (+32.1% YoY) and net profit of RMB 1.08 billion (+147.1% YoY), with robust growth across smartphone, automotive, and AR/VR businesses. Optical components revenue grew to RMB 5.48 billion (+26.9% YoY), while optoelectronic products revenue reached RMB 13.19 billion (+35.5% YoY), driven by higher sales of smartphone camera and automotive modules.

Smartphone: focus on high-end products and product mix optimization

The recovery in the smartphone segment prompted a 13.1% YoY growth in smartphone lens shipments (1.32 billion units, greater than the previous guidance) but a 5.9% decline in smartphone camera module shipments (530 million units, a bit smaller than the previous guidance) due to a strategic shift away from low-end products. The improved product mix is expected to enhance ASP and gross margins, with projected 2024 full-year revenue of RMB 12.19 billion for optical components and RMB 23.84 billion for optoelectronic products. The integration of AI in smartphones is driving smarter and more personalized devices, stimulating replacement demand and accelerating camera upgrades, creating new opportunities for the camera module supply chain.

Automotive: Strong development of new energy vehicles drives further expansion of optical product applications

According to data from the China Association of Automobile Manufacturers, in 2024, the production and sales of new energy vehicles reached 12.89 million and 12.87 million units, respectively, representing year-on-year growth of 34.4% and 35.5%. The sales of new energy vehicles accounted for 40.9% of total new vehicle sales, an increase of 9.3 percentage points compared to 2023. With the ongoing electrification, digitalization, and intellectualization of the automotive industry, the demand for cameras in intelligent driving and cabin sensing systems continues to grow, creating new opportunities for manufacturers. Additionally, market requirements for the performance and quantity of perception hardware such as in-vehicle cameras and LiDAR are increasing, further driving the expansion of optical product applications. Furthermore, in February 2025, BYD launched its "Mass Intelligent Driving" strategy, making intelligent driving systems standard across its 100,000/150,000/200,000 RMB vehicle models, with partial adoption in models below 100,000 RMB. We believe this strategy may lead a new wave of industry competition in configurations, and the company, as a leader in in-vehicle lenses, stands to benefit from the penetration of intelligent driving solutions in lower-tier markets and the advancement of high-end intelligent driving.

Company valuation

Considering the recovery in consumer electronics demand and the company's continued push towards high-end smartphone products, which is expected to optimize product portfolio, coupled with the growth in automotive products driven by the penetration of intelligent driving, we anticipate revenue growth. Therefore, we forecast the company's revenue for 2024-2026 to be 36.51/42.54/48.19 billion RMB, with net profits attributable to the parent company of 2.43/3.19/3.94 billion RMB, corresponding to EPS of 2.28/3.02/3.72 RMB. The current stock price corresponds to a PE ratio of 36.0/27.2/22.0x. Overall, given the company's solid leading position, we apply a valuation slightly above the industry average, at 30 times the 2025 PE, resulting in a target price of 97.32 HKD per share. We initiate coverage with an "Accumulate" rating.

Exchange rate: HKD/RMB=0.93

Risk factors

1) The recovery in demand for the smartphone market falls short of expectations; 2) Delays in the delivery of automotive-related projects; 3) Intensified competition in the lens industry.

Financials

Click Here for PDF format...




Recommendation on 17-3-2025
RecommendationAccumulate
Price on Recommendation Date$ 88.200
Suggested purchase priceN/A
Target Price$ 97.320
Writer Info
Megan Tao
(Research Analyst)
Tel: (+852-22776515)
Email:
megantao@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2025 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]